Open AccessMonoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Author(s) -
J. Boucau,
K.W. Chew,
M.C. Choudhary,
R. Deo,
J. Regan,
J.P. Flynn,
C.R. Crain,
M.D. Hughes,
J. Ritz,
C. Moser,
J.A. Dragavon,
A.C. Javan,
A. Nirula,
P. Klekotka,
A.L. Greninger,
R.W. Coombs,
W.A. Fischer,
E.S. Daar,
D.A. Wohl,
J.J. Eron,
J.S. Currier,
D.M. Smith,
J.Z. Li,
A.K. Barczak,
POSITIVES study team,
ACTIV-A Study Team
Publication year - 2022
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/4pex-cz68
Subject(s) - monoclonal antibody , virology , covid-19 , antibody , medicine , immunology , pathology , infectious disease (medical specialty) , outbreak , disease